All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@ecommerce_uk's TRT monitoring approach, fact-checked

UK e-commerce

TikTok creator

6.3K viewsWatch on TikTok→

Quick answer

The creator describes a testosterone increase from 4 nmol/L to 24.5 nmol/L following TRT, a range consistent with treated hypogonadism under UK clinical standards. He acknowledges prior use of non-prescribed anabolic compounds from age 18, which is clinically relevant as prolonged anabolic steroid use can cause persistent HPG axis suppression that may resemble primary hypogonadism. Adequate TRT monitoring requires more than total testosterone, including haematocrit, SHBG, free testosterone, and oestradiol at minimum.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @ecommerce_uk actually say?

The creator claims his testosterone reading went from 4 to 24.5 following TRT, placing him "in the top end of the natural range." He admits he "took stuff I probably shouldn't have" from around age 18, suggesting prior anabolic steroid use may have contributed to his low baseline. He now frames TRT as a health decision, not a performance one, and says he gets blood work done every eight weeks through The Blood Lab.

To his credit, he explicitly tells viewers: "Don't do any of this by me." That disclaimer matters. He's not presenting himself as a template. He's describing his own monitored protocol under clinical supervision. That's a meaningfully different posture from most TRT content on TikTok, which tends to read like a sales pitch with syringes.

Does the science back this up?

The numbers are plausible, but context matters enormously here. A baseline testosterone of 4 nmol/L is consistent with hypogonadism, and 24.5 nmol/L sits at the upper end of the normal adult male reference range in most UK labs, typically 8 to 29 nmol/L. So the trajectory he describes is medically coherent.

Whether regular blood monitoring at eight-week intervals is sufficient depends on what's being tested. Testosterone alone tells you very little. Research by Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established that TRT monitoring should include haematocrit, haemoglobin, PSA in older men, and lipid panels, not just total testosterone. If The Blood Lab is running comprehensive panels, that's appropriate care. If it's just a testosterone number, it's incomplete.

His implied claim that his levels are "natural" because they fall within the reference range is where the science gets more complicated. Being inside a reference range on exogenous testosterone doesn't make the physiology equivalent to endogenous production. The pulsatile release pattern, SHBG dynamics, and LH suppression are all different. Reference ranges are a population statistic, not a biological equivalence certificate.

What did they get wrong (or right)?

He got the monitoring ethos right. Regular blood work is the difference between supervised TRT and reckless self-medication. The eight-week interval aligns reasonably with standard UK clinical guidance for stable patients on TRT.

What's missing, and this matters, is any mention of what else is being monitored. Total testosterone at 24.5 nmol/L sounds tidy, but exogenous testosterone suppresses the HPG axis. His LH and FSH will be near zero. His haematocrit may be elevated. His oestradiol level matters for symptom management and cardiovascular risk. None of that appeared in the video.

His framing of the result as "top end of the natural range" is also technically imprecise. The range is a population reference. His testosterone at 24.5 nmol/L via injected or gel testosterone is pharmacologically maintained, not naturally produced. That's not a moral judgment, it's just an accurate description. Cooper et al. (2021, Clinical Endocrinology) note that total testosterone alone is an inadequate monitoring marker without free testosterone and SHBG, particularly in men with altered binding protein levels.

What should you actually know?

TRT is a legitimate medical treatment for confirmed hypogonadism. It is not a lifestyle upgrade for men with low-normal testosterone who feel a bit tired. The distinction matters because the risks, including polycythaemia, cardiovascular effects, and fertility suppression, are real and dose-dependent.

A baseline of 4 nmol/L, if confirmed on two fasting morning samples with accompanying symptoms, meets clinical criteria for treatment in most UK guidelines. But the prior use of anabolic compounds the creator references is a clinically important detail. Post-cycle suppression can mimic primary hypogonadism. A thorough workup would distinguish the two. It is not clear from this video whether that distinction was made before treatment started.

For anyone watching this and thinking about TRT: the process should start with a GP referral or a regulated telehealth provider, not a blood testing service and a self-directed protocol. Monitoring is necessary but it is not the same as clinical oversight. Blood numbers without clinical interpretation are just numbers.

The bottom line on this video

This is one of the more responsible TRT posts you'll find on TikTok, which is a low bar but still worth saying. The creator is transparent about his history, recommends against copying him, and uses regular blood testing. The scientific gaps are real: the "natural range" framing is imprecise, and the monitoring described sounds incomplete. But the overall message, that TRT should be supervised and tracked, is correct. It just needs more rigour than a single testosterone number to actually be safe.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @ecommerce_uk's TRT monitoring approach, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@ecommerce_uk's TRT monitoring approach, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

The creator describes a testosterone increase from 4 nmol/L to 24.

FormBlends verdict

The creator describes a testosterone increase from 4 nmol/L to 24.5 nmol/L following TRT, a range consistent with treated hypogonadism under UK clinical standards. He acknowledges prior use of non-prescribed anabolic compounds from age 18, which is clinically relevant as prolonged anabolic steroid use can cause persistent HPG axis suppression that may resemble primary hypogonadism. Adequate TRT monitoring requires more than total testosterone, including haematocrit, SHBG, free testosterone, and oestradiol at minimum.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes a testosterone increase from 4 nmol/L to 24.5 nmol/L following TRT, a range consistent with treated hypogonadism under UK clinical standards. He acknowledges prior use of non-prescribed anabolic compounds from age 18, which is clinically relevant as prolonged anabolic steroid use can cause persistent HPG axis suppression that may resemble primary hypogonadism. Adequate TRT monitoring requires more than total testosterone, including haematocrit, SHBG, free testosterone, and oestradiol at minimum.
  • A testosterone level of 4 nmol/L meets UK clinical criteria for hypogonadism when confirmed on two fasting morning samples with accompanying symptoms, per the British Society for Sexual Medicine guidelines (2017).
  • 24.5 nmol/L sits within the upper portion of the standard UK male reference range (8-29 nmol/L), but this does not make exogenous testosterone physiologically equivalent to endogenous production.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A testosterone level of 4 nmol/L meets UK clinical criteria for hypogonadism when confirmed on two fasting morning samples with accompanying symptoms, per the British Society for Sexual Medicine guidelines (2017).
  • 24.5 nmol/L sits within the upper portion of the standard UK male reference range (8-29 nmol/L), but this does not make exogenous testosterone physiologically equivalent to endogenous production.
  • Prior anabolic steroid use, as the creator describes, can cause persistent HPG axis suppression that clinically resembles primary hypogonadism and should be assessed before initiating TRT.
  • Bhasin et al. (2010, JCEM) established that TRT monitoring requires haematocrit, haemoglobin, lipid panels, and PSA in appropriate patients, not total testosterone alone.
  • Exogenous testosterone suppresses LH and FSH to near zero regardless of where total testosterone sits in the reference range, which has implications for fertility and endogenous function.
  • Eight-week blood monitoring intervals are reasonable for stable TRT patients, but blood testing without clinical interpretation by a qualified prescriber is not the same as supervised treatment.
  • TRT is a regulated medical treatment for confirmed hypogonadism, not a general optimisation tool, and should be initiated through a GP or regulated telehealth provider with full diagnostic workup.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

UK e-commerce · TikTok creator

6.3K views on this video

Nothing is done blindly, I have my bloods taken regularly by The Blood Lab #loadupsupps #supplemenets #bloodwork #trt #advice #TheBloodLab

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by UK e-commerce, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.